CWG
ITCI

C WorldWide Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

C WorldWide Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-146,671
Closed -$1.79M – 110
2019
Q1 		$1.79M Hold
146,671
– – 0.02% 97
2018
Q4 		$1.67M Sell
146,671
-52,032
-26% -$840K 0.02% 85
2018
Q3 		$4.31M Buy
198,703
+25,047
+14% +$524K 0.06% 72
2018
Q2 		$3.07M Buy
173,656
+36,253
+26% +$736K 0.04% 86
2018
Q1 		$2.89M Sell
137,403
-85,107
-38% -$1.66M 0.04% 73
2017
Q4 		$3.22M Sell
222,510
-19,646
-8% -$303K 0.05% 71
2017
Q3 		$3.82M Buy
242,156
+24,194
+11% +$355K 0.05% 74
2017
Q2 		$2.71M Buy
217,962
+30,139
+16% +$349K 0.04% 85
2017
Q1 		$3.05M Buy
187,823
+91,775
+96% +$1.33M 0.05% 73
2016
Q4 		$1.45M Buy
96,048
+28,548
+42% +$403K 0.03% 91
2016
Q3 		$1.03M Sell
67,500
-118,000
-64% -$4.77M 0.02% 107
2016
Q2 		$7.2M Buy
185,500
+60,000
+48% +$2.16M 0.14% 44
2016
Q1 		$3.49M Buy
125,500
+1,500
+1% +$50K 0.07% 56
2015
Q4 		$6.67M Buy
+124,000
New +$6.25M 0.12% 49

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

C WorldWide Group's ITCI Position: Q2 2019 in Review

C WorldWide Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2019, closing a stake of 146,671 shares — an estimated $1.79M sold.

C WorldWide Group first reported a position in ITCI in Q4 2015 and held it in 14 quarters. The position peaked at $7.2M in Q2 2016. 126 funds tracked by Wall St. Rank hold ITCI as of Q2 2019.

  • C WorldWide Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 146,671 Intra-Cellular Therapies Inc. shares in Q2 2019, an estimated $1.79M.
  • C WorldWide Group first reported a position in Intra-Cellular Therapies Inc. in Q4 2015 and held it in 14 quarters.
  • C WorldWide Group's Intra-Cellular Therapies Inc. position peaked at $7.2M in Q2 2016.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.